The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials

Angiotensin-converting enzyme 2 (ACE2) is the receptor for COVID-19 (SARs-CoV-2). ACE2 protects the lung and heart from acute respiratory distress syndrome (ARDS) and acute myocarditis and arrhythmias, because it breaks down Angiotensin II, which has inflammatory effects in the lung and heart as wel...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Eugenie R. Lumbers, Sarah J. Delforce, Kirsty G. Pringle, Gary R. Smith
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2020-05-01
Edice:	Frontiers in Medicine
Témata:	renin-angiotensin system (RAS) ACE2 lung injury cardiovascular disease COVID-19 SARS- CoV-2
On-line přístup:	https://www.frontiersin.org/article/10.3389/fmed.2020.00248/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!